McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $52.62 which represents a slight increase of $0.66 or 1.27% from the prior close of $51.96. The stock opened at $52.23 and touched a ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

Analysts reveal how these healthcare giants are primed for massive gains with 2026's game-changing Medicare Advantage boost ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...